SELLAS Life Sciences (SLS) Inventory Average (2013 - 2015)
SELLAS Life Sciences' (SLS) quarterly Inventory Average came in at $1.0 million in Q2 2015, up 160.81% year-on-year from $395500.0 in Q2 2014, and up 59.67% on a QoQ basis from $646000.0 in Q1 2015.
SELLAS Life Sciences (SLS) Inventory Average (2013 - 2015) Analysis & Trends
SELLAS Life Sciences (SLS) has 3 years of Inventory Average data on file, last reported at $1.0 million in Q2 2015.
- On a quarterly basis, Inventory Average rose 160.81% year-over-year to $1.0 million in Q2 2015; TTM through Jun 2015 was $1.0 million, a 160.81% increase from a year earlier, with the FY2014 full-year figure at $520500.0, changed N/A from the prior year.
- Inventory Average for Q2 2015 stood at $1.0 million, up from $646000.0 in the prior quarter.
- Over the last five years, Inventory Average for SLS reached as high as $1.0 million in Q2 2015 and fell as low as $372000.0 in Q1 2014.
- Historically, Inventory Average has averaged $529125.0 across 3 years, with a median of $423500.0 in 2013.
- Across the five-year window, Inventory Average climbed 13.64% in 2014 and soared 160.81% in 2015, its largest moves.
- Year by year, Inventory Average stood at $405500.0 in 2013, then surged by 36.25% to $552500.0 in 2014, then soared by 86.7% to $1.0 million in 2015.
- Per Business Quant data, the three most recent Inventory Average figures were $1.0 million in Q2 2015, $646000.0 in Q1 2015, and $552500.0 in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 644.91 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.96 Bn | 1.96 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.03 Mn |
| Mar 31, 2015 | 646,000.00 |
| Dec 31, 2014 | 552,500.00 |
| Sep 30, 2014 | 441,500.00 |
| Jun 30, 2014 | 395,500.00 |
| Mar 31, 2014 | 372,000.00 |
| Dec 31, 2013 | 405,500.00 |
| Sep 30, 2013 | 388,500.00 |